A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

التفاصيل البيبلوغرافية
العنوان: A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
المؤلفون: National Cancer Institute (NCI), Janssen Scientific Affairs, LLC, Montefiore Medical Center, Memorial Sloan Kettering Cancer Center, AIDS and Cancer Specimen Resource, The Emmes Company, LLC
المصدر: A Multicenter, Open-Label Feasibility Study of Daratumumab With Dose-Adjusted EPOCH in Newly Diagnosed Plasmablastic Lymphoma With or Without HIV
قاعدة البيانات: ClinicalTrials.gov